Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1
Published October 22, 2025 · Recall initiated: September 16, 2025
Summary
FDA records drug Class I recall D-0015-2026, published October 22, 2025 and initiated September 16, 2025. Recalling firm: IntegraDose Compounding Services LLC; Status: Ongoing; Reported quantity: 853/500 mL bags; Lot: Lot #: 20250620OXY-1, Expiration date 10/18/2025. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- IntegraDose Compounding Services LLC
- Distributor
- Nationwide in the USA
- Lot
- Lot #: 20250620OXY-1, Expiration date 10/18/2025
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650June 24, 2026
- FDAfentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water, IntegraDose CompoundingMay 27, 2026
- FDATavaborole Topical solution 5%, 10 mL bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Changodar,October 22, 2025
- FDAPERIFIX FX Continuous Epidural Anesthesia Tray with PERIFIX 17 Ga. x 3-1/2 in. (8.9 cm) Tuohy Epidural NeedleOctober 15, 2025
- FDAfentaNYL Citrate 2,500 mcg/50mL in Sterile Water, 50 mL CADD for Injection, IntegraDose Compounding Services,April 10, 2024
- FDAVasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mLFebruary 21, 2024
Questions about this recall
Was Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1 recalled?
Yes. FDA published recall D-0015-2026 on October 22, 2025. Reported hazard: Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
What should I do if I have this product?
Voluntary: Firm initiated · Letter